Source: FDA, National Drug Code (US) Revision Year: 2021
Paromomycin sulfate is a broad spectrum antibiotic produced by Streptomyces riomosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product. Paromomycin sulfate is designated chemically as 0-2, 6-Diamino-2, 6-dideoxy-β-L-idopyranosyl-(1→3) -0 -β-D-ribofuranosyl-(1→5) -0 -[2-amino-2-deoxy-α -D-glucopyranosyl-(1→4)]-2-deoxystreptamine sulfate (salt). The molecular formula is C23H45N5O14•xH2SO4, with a molecular weight of 615.64 (base).
Its structural formula is:
Each capsule, for oral administration, contains paromomycin sulfate equivalent to 250 mg paromomycin. Each capsule also contains the following inactive ingredients: FD&C Blue #1, D&C Red #28, FD&C Red #40, gelatin and titanium dioxide. The imprinting ink for the 250 mg capsule contains D&C yellow #10, FD&C blue #1, FD&C blue #2, FD&C red #40, iron oxide black, pharmaceutical shellac glaze, and propylene glycol.
| How Supplied |
|---|
|
HUMATIN Capsules each contain paromomycin sulfate equivalent to 250 mg paromomycin, are supplied as follows: NDC 80725-250-01: Bottles of 100 The capsule is Dark Blue Opaque/White Opaque, imprinted with “HP 38” in black ink on the cap and on the body. Manufactures for: Waylis Therapeutics LLC, Wixom, MI 48393 |
| Drug | Countries | |
|---|---|---|
| HUMATIN | Austria, Canada, Estonia, Spain, Italy, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
